A study analysing association between tumor microenvironment, elevated Il6 and severe toxicity or death in Patients with Diffuse-large-B-cell-lymphomaTreated with Axicabtagene Ciloleucel
Latest Information Update: 21 Jul 2020
At a glance
- Drugs Axicabtagene ciloleucel (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions
- 21 Jul 2020 New trial record
- 21 Jun 2020 Results presented at the 25th Congress of the European Haematology Association